R-107 Stops PAH Progression, Reverses Hypertension in Rats

R-107 Stops PAH Progression, Reverses Hypertension in Rats

300644

R-107 Stops PAH Progression, Reverses Hypertension in Rats

An investigational therapy called R-107 completely stopped the progression of pulmonary arterial hypertension (PAH) in a rat model and may become the first medicine to reverse the increasing blood pressure characteristic of the disease, a study suggested. Now, R-107’s developer, Claritas Pharmaceuticals, plans to begin clinical testing in humans. “The data from this study are unprecedented in the scientific literature, and suggest that R-107 is a potentially revolutionary new treatment for PAH,” Claritas said in…

You must be logged in to read/download the full post.